Infectious Disease News Current Issue
The following articles appeared in the print edition of Infectious Disease News.
Table of Contents
- Influenza vaccine ‘desperately’ needs improvement
-
- Collaborating to accelerate a novel vaccine approach
- Arkansas mumps outbreak exceeds 1,000 cases
- CDC: Men exposed to Zika should wait 6 months before sex
- CDC recommends preteens receive only two HPV vaccinations
- Unvaccinated adults cost US $7.1 billion
- FDA issues boxed warning for HBV recurrence from DAA use
- FDA’s blood donation policy for MSM spurs debate
- HHS finalizes MACRA payment system for physicians
-
- ‘Highly misleading’ headlines suggest impending cure for HIV
- Letermovir reaches primary endpoint in phase 3 trial
- CDC warns of infection risk from open-heart surgery devices
- Percentage of Hispanics receiving prompt HIV care below national target
- Phase 3 IGNITE4 trial to examine safety, efficacy of IV eravacycline in cIAIs
- Physicians’ political beliefs may impact patient care
- Priorix, M-M-R II demonstrate similar immune responses, safety profiles
- Q&A: Keeping nonimmunizing families in practices
-
- Record number of STDs reported in US
- Search for RSV vaccine includes new target
- Tenth anniversary of RotaTeq celebrates vaccine's success
- Third area in Florida sees local transmission of Zika
- UV-C light technology reduces CDIs by 25%
- Vaccination of Amish limited 2014 Ohio measles outbreak
- ACIP recommends against using LAIV in US
- Hepatology-infectious disease collaboration brings further breakthrough
-
- The ABCs of antimicrobial drug resistance in gram-negative bacilli Donald Kaye, MD, MACP
- FDA accepts supplemental new drug application seeking to expand Avycaz label
- Biologics associated with increased risk for herpes zoster in immunocompromised patients
- Canadian patients with HCV often restricted from DAA treatment
- Cat scratch disease in US primarily affects South, children
- Death rates for many communicable diseases fell in past decade
- Deworming drugs show promise against hypervirulent C. difficile
- Half of MDR-HAIs have evidence of nosocomial transmission
-
- Higher colistin doses do not improve mortality rates
- Hospital food unlikely source for C. difficile acquisition
- Malaria death rate drops in sub-Saharan Africa
- MRSA likely to persist in nursing homes; large-scale outbreaks doubtful
- New evidence supports link between Zika virus infection, Guillain-Barré syndrome
- Only 35% of baby boomers diagnosed with HCV in ED linked to care
- PrEP deemed cost-effective in the Netherlands
- Rapid decline in acellular pertussis vaccine protection warrants review
-
- RDTs decrease risk for mortality from bloodstream infections
- S. aureus widespread among children living with industrial hog operation workers
- Suboptimal ART adherence associated with inflammation despite viral suppression
- Antibiotic-resistant pathogens often found on nurses’ scrubs
- Automated analysis of EHR data could identify candidates for PrEP
- Ebola vaccine shows promise in STRIVE trial
- Fatal measles complication more common than previously understood
- Frequent dental checkups lower risk for pneumonia
-
- High lipid levels in HCV patients increase risk for acute MI
- Long-acting monoclonal antibody successful as rescue therapy for MDR HIV
- Omega-3s decreased median triglycerides and CRP in HIV patients on ART
- SCORE trial: ASPs feasible, effective in small community hospitals
- Septic shock and Pseudomonas pneumonia: Is combination therapy necessary? Jeff Brock, PharmD, MBA, BCIDP